{
  "meta": {
    "updated_at": "2025-08-20T23:55:00Z",
    "updated_by": "Nico",
    "version": "v1.7",
    "lang_default": "en"
  },
  "items": [
    {
      "id": "2019-01-dx-staging",
      "year": 2019,
      "type": "diagnosis",
      "status": "done",
      "date_start": "2019-01-15",
      "date_end": "2019-03-01",
      "when_label": "Jan–Mar 2019",
      "title": "Primary diagnosis — T‑lymphoblasts (lymphoma); staging",
      "summary": "Initial workup confirmed lymphoma with T‑lymphoblastic features; baseline tests and staging completed.",
      "details": "Hematology consult, imaging and biopsies established the diagnosis and stage. Baseline cardiac and lab assessment recorded before therapy."
    },
    {
      "id": "2019-03-first-chemo-rt",
      "year": 2019,
      "type": "chemotherapy + radiotherapy",
      "status": "done",
      "date_start": "2019-03-10",
      "date_end": "2019-08-20",
      "when_label": "Mar–Aug 2019",
      "title": "Chemotherapy against lymphoma (T‑lymphoblastic)",
      "summary": "Systemic chemotherapy with supportive care; adjuvant radiation therapy.",
      "details": "Planned cycles with interim response checks and end‑of‑treatment assessment. Radiotherapy delivered for consolidation: ~30 sessions."
    },
    {
      "id": "2020-04-relapse-mi-rt-dx",
      "year": 2020,
      "type": "chemotherapy + radiotherapy + diagnosis",
      "status": "done",
      "date_start": "2020-04-01",
      "date_end": "2020-11-30",
      "when_label": "Apr–Nov 2020",
      "title": "Relapse; severe GI bleed with MI; resumed therapy (with radiotherapy)",
      "summary": "Relapse management included chemo and radiation; massive GI bleed led to myocardial infarction; stabilized and continued therapy.",
      "details": "Severe anemia, tachyarrhythmia and GI ulcer bleeding with MI; transfusions and critical care. Chemotherapy resumed with adjunct radiotherapy (~30 sessions). Diagnostic reassessment performed in this period."
    },
    {
      "id": "2021-05-aggressive-leukocytosis-dx",
      "year": 2021,
      "type": "diagnosis",
      "status": "done",
      "date_start": "2021-05-01",
      "date_end": "2021-05-31",
      "when_label": "May 2021",
      "title": "Aggressive leukemia with extreme leukocytosis — diagnosis",
      "summary": "Leukocytes >300k; diagnosis established; cytoreductive plan initiated.",
      "details": "Rapid leukemic process (Ph+ features later); urgent cytoreduction and transfusion support were indicated."
    },
    {
      "id": "2021-05-2023-09-chemo-aggr-leukemia",
      "year": 2021,
      "type": "chemotherapy",
      "status": "done",
      "date_start": "2021-05-15",
      "date_end": "2023-09-30",
      "when_label": "May 2021–Sep 2023",
      "title": "Chemotherapy against aggressive leukemia",
      "summary": "Prolonged systemic chemotherapy to reach CAR‑T eligibility and disease control.",
      "details": "Escalating/adjusted regimens aimed at bringing leukocytes below CAR‑T threshold; infections managed along the way."
    },
    {
      "id": "2022-03-26-neuro-shock",
      "year": 2022,
      "type": "event",
      "status": "done",
      "date_start": "2022-03-26",
      "date_end": "2022-04-30",
      "when_label": "Mar–Apr 2022",
      "title": "Systemic shock with paralysis and amnesia",
      "summary": "Resuscitated; prolonged neurological deficits with gradual recovery.",
      "details": "Acute collapse required resuscitation. Afterwards: paralysis, memory loss and slowed cognition; stepwise recovery under neurologic guidance."
    },
    {
      "id": "2022-10-invasive-fungal-sepsis",
      "year": 2022,
      "type": "event",
      "status": "done",
      "date_start": "2022-10-01",
      "date_end": "2022-10-31",
      "when_label": "Oct 2022",
      "title": "Invasive fungal infection with sepsis",
      "summary": "Severe oropharyngeal focus with systemic involvement; treated successfully.",
      "details": "Managed in hospital with antimicrobials; concurrent arrhythmias and prior micro‑stroke noted during 2022."
    },
    {
      "id": "2022-12-covid-icu-gi-bleed",
      "year": 2022,
      "type": "event",
      "status": "done",
      "date_start": "2022-12-10",
      "date_end": "2023-01-15",
      "when_label": "Dec 2022–Jan 2023",
      "title": "COVID‑19 pneumonia (ICU, intubation) and GI bleed; recovery",
      "summary": "Critical COVID‑19 with intubation; GI bleeding; coma; unexpected recovery.",
      "details": "Rapid pneumonia progression on immunosuppression; post‑ICU recovery followed by stabilization."
    },
    {
      "id": "2023-06-respiratory-arrest-sepsis",
      "year": 2023,
      "type": "event",
      "status": "done",
      "date_start": "2023-06-01",
      "date_end": "2023-09-30",
      "when_label": "Jun–Sep 2023",
      "title": "Respiratory arrest (revived) and bacteremia; high‑dose chemo",
      "summary": "Cardiorespiratory event reversed; rare cardiac‑source bacteremia treated; intensified chemo to reach CAR‑T criteria.",
      "details": "Therapy escalated to reduce leukocytes below CAR‑T threshold; infections managed."
    },
    {
      "id": "2023-10-car-t",
      "year": 2023,
      "type": "transplant",
      "status": "done",
      "date_start": "2023-10-15",
      "date_end": "2023-11-30",
      "when_label": "Oct–Nov 2023",
      "title": "CAR‑T cell therapy",
      "summary": "CAR‑T administered; severe toxicity managed (fever, neurologic and cardiac events).",
      "details": "High fever, vomiting, transient leg paralysis, cardiac event and profound memory loss consistent with neurotoxicity; gradual recovery thereafter."
    },
    {
      "id": "2024-01-allo-sct-brother-bradonor",
      "year": 2024,
      "type": "transplant",
      "status": "done",
      "date_start": "2024-01-01",
      "date_end": "2024-02-01",
      "when_label": "Jan 2024",
      "title": "Allogeneic stem‑cell infusion — brother donor (BRADONOR)",
      "summary": "Allogeneic stem cells infused as consolidation after CAR‑T.",
      "details": "Engraftment phase under strict infection control; outpatient recovery thereafter."
    },
    {
      "id": "2024-07-abdominal-mass-hl",
      "year": 2024,
      "type": "diagnosis",
      "status": "done",
      "date_start": "2024-07-01",
      "date_end": "2024-07-31",
      "when_label": "July 2024",
      "title": "Large abdominal mass; aggressive Hodgkin lymphoma",
      "summary": "New HL diagnosed, distinct from earlier disease; therapy plan adjusted.",
      "details": "Considered possibly related to prior immunotherapy background; oncology proposed a new chemotherapy strategy."
    },
    {
      "id": "2024-08-2025-06-chemo-rt",
      "year": 2024,
      "type": "chemotherapy + radiotherapy",
      "status": "done",
      "date_start": "2024-08-01",
      "date_end": "2025-06-30",
      "when_label": "Aug 2024–Jun 2025",
      "title": "Escalated chemo → septic complication → switch to effective regimen; radiotherapy ×30",
      "summary": "Initial heavy dose caused sepsis; switched to better‑tolerated regimen; adjuvant radiotherapy (30 sessions).",
      "details": "After septic episode, regimen adjusted; subsequent cycles showed effect. Radiotherapy added for consolidation (30 daily sessions)."
    },
    {
      "id": "2025-06-relapse-Ph-pos",
      "year": 2025,
      "type": "diagnosis",
      "status": "done",
      "date_start": "2025-06-20",
      "date_end": "2025-06-30",
      "when_label": "Late Jun 2025",
      "title": "Rising leukocytes; Ph+ lymphoid cells detected",
      "summary": "Leukocytes increased from ~35k to ~67k within days; Ph+ lymphoid lineage identified.",
      "details": "Oncology proposed oral chemotherapy followed by TKI (ponatinib) once stabilized."
    },
    {
      "id": "2025-07-oral-chemo-14",
      "year": 2025,
      "type": "chemotherapy",
      "status": "current",
      "date_start": "2025-07-15",
      "date_end": null,
      "when_label": "Now",
      "title": "Oral multi‑agent chemotherapy (14 doses)",
      "summary": "Structured per‑oral regimen at home, total of 14 doses.",
      "details": "Complex oral combination with interim labs and tolerance monitoring; decision points defined after completion."
    },
    {
      "id": "plan-2025-support-recovery",
      "year": 2025,
      "type": "rehab",
      "status": "planned",
      "confidence": "high",
      "date_start": null,
      "date_end": null,
      "when_label": "Post‑chemo (TBD)",
      "title": "Support and functional recovery",
      "summary": "Structured supportive care and rehabilitation after the current course.",
      "details": "Scope and schedule to be adjusted to post‑chemo status and lab dynamics."
    },
    {
      "id": "plan-2025-tki-lifelong",
      "year": 2025,
      "type": "other",
      "status": "planned",
      "confidence": "medium",
      "date_start": null,
      "date_end": null,
      "when_label": "After stabilization (TBD)",
      "title": "Tyrosine‑kinase inhibitor (ponatinib) — long‑term",
      "summary": "Initiate TKI maintenance after cytoreduction; likely long‑term or lifelong.",
      "details": "Start after acceptable hematologic control; monitor response and adverse events; dose optimization expected."
    },
    {
      "id": "plan-2025-re-irradiation",
      "year": 2025,
      "type": "other",
      "status": "planned",
      "confidence": "high",
      "date_start": null,
      "date_end": null,
      "when_label": "If indicated (TBD)",
      "title": "Potential repeat radiotherapy",
      "summary": "Consider re‑irradiation if disease control requires it.",
      "details": "To be discussed by tumor board; depends on imaging and prior dose constraints."
    },
    {
      "id": "plan-2025-chemo-switch",
      "year": 2025,
      "type": "chemotherapy",
      "status": "tentative",
      "confidence": "low",
      "date_start": null,
      "date_end": null,
      "when_label": "If current regimen underperforms (TBD)",
      "title": "Possible switch of current chemotherapy protocol",
      "summary": "Protocol change may be required based on response or toxicity.",
      "details": "Decision after reassessment of labs, imaging and tolerance; alternative protocol to be selected if indicated."
    },
    {
      "id": "plan-2025-next-line-chemo",
      "year": 2025,
      "type": "chemotherapy",
      "status": "tentative",
      "confidence": "low",
      "date_start": null,
      "date_end": null,
      "when_label": "If needed (TBD)",
      "title": "Possible additional chemotherapy line",
      "summary": "Another line may be required depending on disease dynamics.",
      "details": "To be defined by tumor board after current course evaluation."
    },
    {
      "id": "plan-2026-repeat-allo-sct",
      "year": 2026,
      "type": "transplant",
      "status": "tentative",
      "confidence": "medium",
      "date_start": null,
      "date_end": null,
      "when_label": "2026 (possible)",
      "title": "Possible repeat allogeneic stem‑cell transplant",
      "summary": "Option if disease course necessitates definitive consolidation.",
      "details": "Contingent on response to TKI and chemo; requires donor/center evaluation and risk–benefit review."
    }
  ],
  "changelog": [
    { "date": "2025-08-20", "note": "2019 chemo marked with radiotherapy (×30). 2020 period extended to Apr–Nov and marked with diagnosis + radiotherapy (×30). May 2021 diagnosis set to exact month; added May 2021–Sep 2023 leukemia chemotherapy block. 2024–2025 block marked 'chemotherapy + radiotherapy'. Other prior date fixes preserved." }
  ]
}
